Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel PEX1 coding mutations and 5' UTR regulatory polymorphisms.

Megan A Maxwell1, Pamela B Leane, Barbara C Paton

  • 1Cell Biology Program, Eskitis Institute for Cell and Molecular Therapies, Nathan, Queensland, Australia.

Human Mutation
|August 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatocyte-specific deletion of peroxisomal protein PEX13 results in disrupted iron homeostasis.

Biochimica et biophysica acta. Molecular basis of disease·2020
Same author

Impaired neurogenesis and associated gliosis in mouse brain with PEX13 deficiency.

Molecular and cellular neurosciences·2017
Same author

Peroxisomal protein PEX13 functions in selective autophagy.

EMBO reports·2016
Same author

Mitochondrial changes and oxidative stress in a mouse model of Zellweger syndrome neuropathogenesis.

Neuroscience·2016
Same author

Mechanism of impaired microtubule-dependent peroxisome trafficking and oxidative stress in SPAST-mutated cells from patients with Hereditary Spastic Paraplegia.

Scientific reports·2016
Same author

A new disaster victim identification management strategy targeting "near identification-threshold" cases: Experiences from the Boxing Day tsunami.

Forensic science international·2015
Same journal

Single-Cell and Multiomics Characterization of p21 in Cancer Progression and Therapeutic Sensitivity.

Human mutation·2026
Same journal

COL1A1 and SERPINE1 as Potential Therapeutic Targets in Diabetic Retinopathy: A Study Incorporating RNA Transcriptomics, Single-Cell RNA Sequencing, and Proteomics.

Human mutation·2026
Same journal

Autosomal Dominant Missense <i>DAG1</i> Variant Linked to Mild-Moderate LGMD R16.

Human mutation·2026
Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026
Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026
Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
See all related articles

This study identifies novel PEX1 gene mutations and polymorphisms in Zellweger spectrum disorders. These genetic variations, including regulatory polymorphisms, contribute to disease severity and phenotypic heterogeneity in affected individuals.

Area of Science:

  • Genetics
  • Biochemistry
  • Molecular Biology

Background:

  • Zellweger spectrum disorders are a group of inherited diseases affecting peroxisome function.
  • Mutations in the PEX1 gene are a common cause, accounting for about two-thirds of patient mutations.
  • PEX1 encodes a AAA ATPase protein crucial for importing proteins into peroxisomes.

Purpose of the Study:

  • To identify and characterize novel PEX1 gene mutations and polymorphisms in an Australasian cohort.
  • To investigate the impact of these genetic variations on PEX1 protein function and Zellweger spectrum disease phenotypes.
  • To explore the role of PEX1 promoter polymorphisms in disease heterogeneity.

Main Methods:

  • Mutation screening of the PEX1 gene in Zellweger spectrum patients.

Related Experiment Videos

  • Analysis of PEX1 mutations and their correlation with disease severity.
  • Functional studies using cultured skin fibroblasts to assess peroxisomal protein import.
  • Reporter assays to evaluate the regulatory effects of PEX1 5' UTR polymorphisms on gene expression.

    • Main Results:

    • Four novel PEX1 mutations and two polymorphisms were identified.
    • Severe Zellweger phenotypes were associated with mutations leading to premature termination codons (c.1108_1109insA and c.2391_2392delTC).
    • A milder phenotype was linked to compound heterozygosity for missense mutations (I989T and R998Q) in the AAA domain, with residual PTS1 import at ~20% of normal.
    • PEX1 5' UTR polymorphisms (c.-137T>C and c.-53C>G) differentially affected PEX1 expression, with combined presence leading to near-normal expression.

    Conclusions:

    • Novel PEX1 mutations contribute to the genetic basis of Zellweger spectrum disorders.
    • The location and type of PEX1 mutation significantly influence disease severity.
    • PEX1 promoter polymorphisms can modulate PEX1 expression, potentially contributing to phenotypic heterogeneity, especially in conjunction with other PEX gene mutations.